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Perioperative nutrition: what do we know?
Introduction
Disease-related malnutrition is often prevalent in hospitalized 
patients and results in increased morbidity, mortality and 
healthcare costs.1,2 Historically there has been some confusion on 
the classification of disease-related malnutrition due to the variety 
of definitions that existed but recently an International Guideline 
Committee developed a consensus approach to defining adult 
malnutrition in clinical settings.3  Due to the past lack in clear 
classification of malnutrition, the actual prevalence of malnutrition, 
using defined criteria, is unknown.  The prevalence varies depending 
on the type of disease ranging for instance from 25% in chronic 
obstructive pulmonary disease to 85% in pancreatic cancer and 
88% in head and neck cancer patients.1  Furthermore, patients 
with preoperative malnutrition have a significantly higher risk of 
postoperative complications and death along with increased hospital 
length of stay (LOS) and overall costs.2,4 Postoperative malnutrition 
or delayed / insufficient nutrition support has also been associated 
with higher risk for complication rates and mortality.4 This suggests 
that perioperative nutrition support may positively affect outcomes.4  
This review will focus on postoperative nutritional support and 
arginine supplementation in surgical patients.
Effect of nutrition on patient outcomes 
Several studies and reviews have demonstrated the benefits of 
nutrition therapy, specifically enteral nutrition (EN) in critically ill 
patients including surgical patients.4  A meta-analysis by Stratton 
et al identified functional benefits of enteral nutrition support 
administered to hospitalized patients in varied clinical settings as 
well as in postoperative surgical patients. These benefits included 
reduced prevalence of complications, reduced mortality rates, and/
or shorter length of stay.1  The limited available data on the direct 
assessment of cost-savings arising from improved outcomes 
associated with EN therapy indicate that it is a cost effective 
treatment.1 Similarly, there are also limited data in this regard which 
compare EN to parenteral nutrition (PN) as well as preoperative to 
postoperative nutrition with regards to treatment effect and the cost 
to benefit ratio.1 
Traditional management of surgical patients
Traditional perioperative management of patients entailed keeping a 
patient nil per os (NPO) from the previous evening (six to 12 hours 
preoperatively) and postoperatively for several days. Only IV fluids 
were administered until bowel function returned, this being perceived 
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as the passing of flatus, a bowel movement or the presence of bowel 
sounds. Once bowel function returned, enteral nutrition or diet per 
mouth was initiated. The reasons for this approach was related to the 
fear for anastamotic breakdown and prolonged feeding intolerance 
due to postoperative ileus (POI) which was seen as an inevitable 
consequence of surgery. Traditionally also, a more conservative 
dietary progression was followed which consisted of a clear liquid 
diet, followed by a full liquid diet advancing to a soft or normal diet.5 
This slow commencement of dietary intake has limited nutritional 
value and along with the delayed commencement of nutritional 
support is known to contribute to the development of nutritional 
deficits and accentuated postoperative weight loss.2 
Current perioperative patient management 
recommendations
Currently an important focus of perioperative patient management 
is the enhanced recovery of patients after surgery (ERAS) or the 
so-called “fast track” protocols.4 The key aspects of ERAS from a 
metabolic and nutritional point of view are avoidance of long periods 
of preoperative fasting, re-establishment of oral feeding as soon 
as possible after surgery, integration of nutrition support, including 
administration of specialized nutrients into the overall management 
of the patient, metabolic control, early mobilization and reduction 
of factors known to exacerbate stress-related catabolism or impair 
gastrointestinal function (Table I). 5-7 
Table I: Components of enhanced recovery after surgery (ERAS) 
protocols.4,5,7 
Preoperative period
Preoperative counselling
Prebiotics/probiotics administration
Oral carbohydrate load
Fasting limited to three hours
No bowel preparation
Omission of nasogastric tube
Perioperative period
Nasogastric tube removal
Transverse incision
Administration of specialized nutrients
Postoperative period
Nasogastric tube removed
Avoidance of postoperative drains
Immediate postoperative fluid and diet initiation
Epidural analgesia
Diet initiation on postoperative day 1
Aggressive mobilisation program
Findings from various studies on ERAS indicate possible benefits 
from these programs for both patient and institution, thus 
contradicting traditional management. Some of these benefits 
include shorter length of stay (LOS) in hospital, earlier return of 
bowel function, decreased length of time to mobilization, fewer 
postoperative complications, ability to tolerate solid food sooner and 
lower readmission rate 30 days postoperatively. In addition, there 
was no difference in reported pain or fatigue in patients treated with 
the ERAS protocols when compared with traditional management. 
It should, however be borne in mind that the ERAS protocols 
incorporate a number of components and as such it is difficult to 
associate  the claimed benefits with one specific component such 
as nutritional support. 5
Regarding perioperative nutrition support, the ESPEN guidelines on 
EN in surgery and organ transplantation recommend that patients 
with severe nutritional risk should receive nutritional support 10–14 
days prior to major surgery even if it means delaying surgery (Grade 
A evidence). The enteral route is preferred except in patients with 
intestinal obstruction, ileus, severe shock or intestinal ischaemia 
(Grade C evidence).6 Preoperative fasting from midnight is 
unnecessary in most patients (Grade A evidence) with solids allowed 
up to six hours in patients with no specific risk for aspiration and clear 
fluids up to two hours preoperatively.6,8 Patients who do not meet 
their requirements from a normal diet should be encouraged to take 
oral supplements (Grade C evidence) or enteral nutrition should be 
administered prior to hospital admission.6 In severely undernourished 
patients who cannot be fed adequately enterally, parenteral nutrition 
is recommended but this route is costly and mostly administered 
in hospital.8  Early postoperative feeding, whether it is via normal 
food intake or enteral feeding is recommended and, in the case 
of colon resection, even within hours after surgery. Care should 
be taken to adapt oral intake according to individual tolerance as 
well as to the type of surgery. In cases where enteral nutrition is not 
feasible in undernourished patients, parenteral nutrition should be 
administered.8
With regards to the early enteral nutrition component of ERAS, the 
first study on this aspect was conducted in 1979. Currently there are 
about 30 randomised control tials on early enteral nutrition, most of 
them on surgical oncology patients. These studies do not support 
the traditional nutritional management of postoperative patients 
and clearly indicates the positive effects on outcomes in patients 
receiving early EN. A recent meta-analysis confirmed the statistically 
significant reduction in total postoperative complications following 
surgery with the introduction of nutritionally significant nutrition, 
early, postoperatively within 24 hours.9
What is currently happening postoperatively?
A study comparing critically ill surgical and medical patients in 
relation to the nutritional support they received during the course 
of their illness reported that surgical patients had received less 
nutrition support and were more at risk for iatrogenic malnutrition 
than internal medicine patients. 4
More specifically, surgical patients were less likely to receive EN, 
more likely to receive parenteral nutrition (PN), and when started 
on EN it was found that they received EN, on average, 21 hours 
later than medical patients. As a result, surgical patients received 
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a lower proportion of their initial prescription from EN alone or even 
from a combination of EN, propofol and appropriate PN.4 Surgical 
subgroup comparisons indicated that those patients undergoing 
cardiovascular and gastrointestinal surgery were more likely to 
receive PN, less likely to receive EN as well as delayed EN, and lower 
total nutrition adequacy when compared with other surgical groups.4
Among the reasons identified for the delay in initiating nutrition 
support were anticipated return of the patient to surgery and 
possible extubation with subsequent oral intake. Another reason 
for the delay was hemodynamic instability, especially in the 
cardiovascular surgical subgroup. This is in contrast to consistent 
data indicating that early EN is associated with improved outcomes 
in hemodynamically compromised critically ill patients.  In the case 
of distal gastrointestinal anastamoses, the delay centered on the 
belief that EN might compromise the integrity of the anastomosis,4 
indicating that traditional beliefs still persist among surgeons, 
despite the established ERAS protocols. 
Proposed strategies to overcome these perceived barriers are trophic 
feeding, administration of EN at reduced doses for the first day with 
subsequent reassessment the following day, the implementation of 
feeding protocols along with protocols for blood glucose control, the 
utilization of motility agents and small bowel feeding tubes.4
Immunonutrition: an integral element of ERAS
Immunonutrition therapy has also been demonstrated to result in 
fewer infectious complications and reduced length of stay in hospital 
in selected populations of surgical patients. However, the clinical 
benefit of immunonutrition remains controversial with some studies 
indicating potential harm, especially in patients with underlying sepsis. 
In addition, the limited experience of immunonutrition in patients with 
gastrointestinal intolerance has also been documented.10 In order 
to address these limitations, the approach to pharmaconutrition 
therapy has evolved to administering immunonutrients on their 
own, separate from other forms of nutrition.11  In summary, current 
clinical practice recommendations of the Canadian Clinical Practice 
Guidelines (CCPG), European Society for Parenteral and Enteral 
Nutrition (ESPEN) on both enteral and parenteral nutrition in surgery, 
and the Society of Critical Care Medicine (SCCM) and American 
Society for Parenteral and Enteral Nutrition (ASPEN) guidelines 
on immunonutrients for elective surgery, specifically relating to 
arginine, are inconsistent or absent.6,8,11 There is also a paucity of 
practice guidelines regarding the use of glutamine, omega-3-fatty 
acids and antioxidant nutrients in such patients. 
With regard to role of arginine in major surgery, a deficiency state is 
thought to develop which results in an immunosuppression and an 
increased risk for infectious complications. Patients with sepsis and 
surgical trauma appear to regulate arginine metabolism differently, 
with lower arginine circulating levels and increased arginase activity 
having been observed in surgical trauma when compared with that 
of sepsis.12 An arginine deficiency appears most likely in the earlier 
stages of sepsis and deteriorates progressively with the severity 
of sepsis.10  It would therefore appear that the effect of arginine 
supplementation may differ in different patient populations.
A recent meta-analysis on the evidence for specifically 
supplementing arginine in surgical patients, which included thirty 
five studies, reported that arginine supplementation resulted in 
a considerable reduction in infectious complications and shorter 
length of hospital stay without having an overall significant effect 
on mortality when compared with standard care. Limitations of 
the meta-analysis include the time span over which the studies 
included were conducted (two decades) and the small nature of the 
studies. The heterogeneity of the populations studied and included 
in the meta-analysis was also addressed. In subgroup analysis, 
arginine supplementation seemed to have a consistent beneficial 
effect across all types of patients with gastrointestinal (GI) and non-
GI surgery in term of duration of hospitalisation, with an average 
reduction in LOS of 2 days in GI surgery and 3.7 days in non-GI 
surgery. However, no substantial reduction in LOS was observed in 
lower GI surgical patients as a subset.13 
A similar meta-analysis on the use of arginine in combination with 
other immunonutrients, reported that immunonutrition formulas 
containing both arginine and fish oil reduced the risk for acquired 
infections, reduced wound complications, and shortened hospital 
LOS in patients at high risk of postoperative complications.12 The 
patient populations included in this meta-analysis included patients 
with GI malignancies, general abdominal surgery, head and neck 
malignancy and cardiac surgery. The treatment benefit was noted 
in all such groups of patients and did not depend on the timing 
of initiation, thus suggesting that both peri- and postoperative 
supplementation may be beneficial. 
Another study2 concluded that the largest treatment effect of argi-
nine supplementation was seen with perioperative administration 
of arginine-supplemented diets and hypothesized that the use of 
arginine-supplemented diets both pre-and postoperatively may be 
beneficial. The authors proposed that arginine-supplemented diets 
can overcome the arginine deficiency observed in surgical patients by 
increasing systemic arginine availability through supraphysiological 
supplementation doses (Figure 1).  Furthermore, it was proposed 
that the addition of omega 3 fatty acids along with arginine probably 
blunted the upregulation of arginase 1, the enzyme responsible 
for arginine degradation and for which elevated levels have been 
reported in surgical patients, whereas the inclusion of vitamin 
A supplementation could downregulate arginase 1 expression, 
thus resulting in lower levels of the enzyme. It is currently not 
clear though how elective surgery patients who develop systemic 
infections should be treated and further studies are necessary 
before an optimal nutrition support therapy regimen with regard to 
immunonutrients in this specific population is established.12 
There are currently no recommendations regarding glutamine 
supplementation in conjunction with arginine in surgical patients. 
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Glutamine is considered a conditionally essential amino acid in 
catabolic states due to the muscle stores being rapidly depleted. 
Glutamine supplementation, especially high dose parenteral 
supplementation, in elective surgical patients is documented to 
reduce infectious complications and LOS.14 In addition to glutamine 
supplementation itself, a recent study conducted found that that 
an arginine-supplemented immune-enhancing diet increased 
plasma glutamine levels.15 The speculative effects (Table II) of the 
potentially beneficial effects of combined glutamine and arginine 
supplementation remain to be substantiated.   
Table II: Speculative effects of combined arginine and glutamine14
Glutamine Arginine Glutamine + arginine
Immune response ↑↑ ↑↑ ↑↑↑
Oxidative stress ↓↓ ↓ or → ↓↓
Inflammatory response ↓↓ ↓ or → ↓↓
Nitric oxide production ↓ or → ↑↑ →
Gut barrier ↑↑ ↑ ↑↑
Insulin resistance ↓ ↓ ↓↓
Wound healing → ↑↑ ↑↑
Conclusion
Early postoperative nutrition is recommended in all surgery 
patients. All patients undergoing elective surgery with substantial 
risk of infectious complications should be prescribed arginine-
supplemented diets along with omega-3 fatty acids preferably 
pre- and postoperatively. No recommendation can be made on the 
combined supplementation of glutamine and arginine.
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Figure 1: Proposed mechanism by which immunonutrients could possibly 
increase circulating arginine levels in surgical patients
